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Abstract 
The effects of the exudate of Aloe barbadensis leaves on oxidative stress and some antioxidant 
status of streptozotocin induced - diabetic rats were studied. There was significant reduction in 
scavenging enzymes like superoxide dismutase (SOD) activity and significant increase in signs 
of oxidative tissue damage, such as lipid peroxidation products (plasma MDA) in streptozotocin 
induced - diabetic rats. Treatment with Aloe barbadensis (150mg/kg) increased antioxidant 
enzymes like SOD activities and significantly reduced lipid peroxidation products. This study 
shows that high blood sugar leads to increased oxidative stress and that exudates of Aloe 
barbadensis leaves possessed antioxidant activity as shown by increased scavenging SOD 
activity and decreases in lipid peroxidation products levels. 
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Diabetes mellitus is a metabolic disease 
characterized by hyperglycaemia and glycosuria 
due to absolute or relative lack of insulin. 
Diabetes mellitus is considered a chronic 
disease, not yet curable by any known orthodox 
medicine. 
 
Oxidative stress is reported to be increased in 
patients with diabetes mellitus1. Accumulating 
evidence suggests that oxidative cellular injury 
caused by free radicals contributes to the 
development of diabetes mellitus2.  Reactive 
oxygen species generated in the cells are 
scavenged by antioxidant enzymes. Moreover 
diabetes also induces changes in the tissue 
content and activity of the antioxidant enzymes3. 
 
Many minor components of foods, such as 
secondary plant metabolites, have been shown to 
alter biological processes, which may reduce the 
risk of chronic diseases in humans4. Aloe 
barbadensis miller (otherwise known as Aloe 
vera) is a perennial plant belonging to the family 
liliaceae and with its origin in the North Africa.  
Aloes have long been used all over the world for 
their various medicinal properties.  Aloe vera is 
one of the plants considered to have a 
hypoglycemic effect and many diabetic subjects 
take the gel because of its hypoglycaemic 
effect5.  Aloe vera not only possesses 
hypoglycaemic activity but is hypotensive, 
hepatoprotective and also blood purifier6. 
 
In view of the above consideration the present 
study was designed to investigate the protective 
effect of Aloe vera on plasma lipid peroxide and 
superoxide dismutase (SOD) activity, an 
antioxidant enzyme. 
 
MATERIALS AND METHODS 
 
Plant material 
Fresh spiny leaves of Aloe vera were collected 
from aloe plant growing from the horticultural 
unit of Imo State University, Owerri.  Botanical 
identify was kindly confirmed by Dr. C. I. 
Onuoha of Plant Science and Biotechnology 
Department of Imo State University, Owerri. A 
voucher specimen of the plant is deposited in 
Imo State University, Owerri. 
Preparation of the crude extract 
Fresh spiny leaves of Aloe barbadensis were 
collected and washed without squeezing to 
remove debris and dust particles. Large 
quantities of the leaves were cut open and the 
inside was collected or extracted, weighed and 
stored for use. 
 
A measured volume of the extract (80ml) was 
put in a weighed evaporating dish.  The dish 
containing 80ml of extract was evaporated to 
dryness by weight difference; the weight of the 
active ingredient in the 80ml of the extract (the 
solid residue (2.4g) referred to as extract) was 
determined. Appropriate concentrations of the 
extract were made in distilled water for 
experiments and expressed as mg/ml. 
 
Acute toxicity test 
The acute toxicity (LD50) of the extract was 
estimated in 30 Albino rats by oral compulsion 
as described by Miller and Tainter7. In brief, the 
method involved the administration of 5 
different doses of the extract to 5 groups of rats 
(6 rats per group). The number of deaths in each 
group within 24 hours was recorded. The LD50 
was estimated from the graph of percentage (%) 
mortality (converted to probit) against log-dose 
of the extract-probit 5 being 50%. 
 
Phytochemical tests 
The chemical classes of constituent in the 
freshly prepared extract were detected using 
standard phytochemical reagents and procedures 
as described by Trease and Evans8. 
 
In general, tests for the presence or absence of 
phytochemical compound using the above 
methods involve the addition of an appropriate 
chemical agent to the crude material in a test 
tube. The mixture is then shaken vigorously or 
gently as the case may be. The presence or 
absence of saponins, flavonoids, tannins, 
alkaloids etc. was observed. 
 
Animals 
Wistar albino rats weighing 150-200g were used 
in this study.  All the rats were kept at room 
temperature in the animal room of College of 
Medicine and Health Science, Imo State 
University, Owerri.  They were allowed free 
access to water and feed diet (product of Pfizer 
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Nigeria Ltd.) throughout the period of the 
experiment. 
 
Eighteen rats, included for the study, were 
divided into 3 groups, 2 were made diabetic by 
intraperitoneal injection of 65mg/kg body 
weight of streptozotocin (STZ) (Sigma, St. 
Louis, MO, USA) dissolved in citrate buffer 
(0.01M, pH 4.5). Diabetes was confirmed by the 
determination of fasting blood glucose 
concentration on the third day post 
administration of STZ showing fasting blood 
glucose levels above 250mg/dl. 
 
Body weight and fasting blood glucose levels of 
all the rats were determined before the start of 
the experiment.  Rats were divided into the 
following groups. 
Group 1: Control, given only the citrate buffer 
(0.01M, pH 4.5);  
Group 2:  Streptozotocin induced 
diabetic, made with a single dose of 
streptozotocin (65mg/kg body weight) by 
intraperitoneal route;  
Group 3: Diabetic rats treated with Aloe 
barbadensis 150mg/kg/once a day, daily. 
Treatment was by oral compulsion. 
 
After 4 weeks of treatment the body weight and 
fasting blood glucose of the animals were again 
determined. Blood was collected and transferred 
in an EDTA anticoagulated tube for plasma 
separation. 
 
Experimental and analytical procedure 
Twelve hours after the last treatment and after 
the last feed given, 4 ml of blood was collected 
from all the rats. The blood collected was 
transferred onto an EDTA anticoagulated tube. 
 
 
The anticoagulated blood was then centrifuged 
using Wisperfuge model 1384 centrifuge 
(Tamson, Holland) for 15min to facilitate 
separation. The plasma thus obtained was used 
for malondialdehyde (MDA) (product of lipid 
peroxidation) estimation. Plasma MDA was 
measured by a thiobarbituric acid assay 
procedure9, which was calibrated using 1, 1, 3, 3 
– tetraethoxypropane (Sigma Chemicals, St. 
Louis, MO, USA) as a standard. Results were 
expressed as nanomoles of MDA per millimetre 
of serum. 
 
The remaining packed RBCs were washed thrice 
with normal saline. Haemolysis was performed 
by pipetting out 1ml of washed red blood 
suspension in ice-cold distilled water. 
Erythrocyte ghosts were sedimented in a high-
speed refrigerated centrifuge at 12000 rpm for 
40min. The cell content was separated out 




The results were analyzed using Duncan 
Multiple range test. All data are expressed as 
mean ± SD. Differences between groups were 




Table 1 shows the results of the analysis, in 
which there was a significant increase (p<0.05) 
in fasting blood glucose and a comparative 
decrease (p<0.05) in body weight when 
compared with the normal control. There was a 
slight increase in body weight and a significant 
decrease in fasting blood glucose in diabetic rats 
treated with Aloe barbadensis. 
 
Table 1: The mean values of body weight and blood glucose in normal, diabetic and Aloe 
barbadensis treated diabetic rats. Values are expressed as mean ± SD. (n = 6) 
Body weight Mean initial  
weight (g) 






    Initial After 4weeks 
Normal Control 136.32±9.8 173.79±11.8 38.6±2.2 94.54±2.6 97.42±2.6 
Diabetic control   138.26±10.54 122.48±8.5 14.2±2.1** 252.22±3.0* 261.42±5.6 
Treated diabetic rats 137.8±11.8 133.6±12.2 5.5±2.23** 255.56±7.2* 107.71±4.4 
* Significantly different from normal control group (p<0.05). 
** Significantly different from normal and diabetic controls (p<0.05). 
 80 
Table 2: The mean values of lipid peroxide 
and vitamins E and C in normal, diabetic and 
Aloe barbadensis treated diabetic rats. Values 
are expressed as mean ± SD. (n = 6). 











* Significantly different from normal control 
group (p<0.05). ** Significantly different from 
normal control and treated diabetic rats 
(p<0.05) 
 
In Table 2 there was a significant increase in 
lipid peroxide levels (p<0.05) in 
streptozotocin induced diabetic rats with 
respect to normal controls. It also shows a 
statistically significant decrease in lipid 
peroxide levels in diabetic rats treated with 
extract of Aloe barbadensis leaves. The 
activities of SOD were significantly higher in 
diabetic rats treated with extract of Aloe 
barbadensis leaves compared to diabetic 
control rats (p<0.05). There was no significant 
difference among the treated diabetic and 
normal groups but there was significant 





Traditional plant remedies have been used for 
centuries in the treatment of diabetes4, but 
only a few have been scientifically evaluated. 
Therefore, we investigated the effect of extract 
if Aloe barbadensis leaves on biomarkers of 
oxidative stress and the antioxidant enzyme 
(SOD) in diabetic rats.  
 
Our data showed that the extract of this plant 
significantly lowered the level of glucose in 
streptozotocin induced diabetic rats. This 
finding is similar to the work reported 
previously by Okyar et al5. 
 
The increase in plasma MDA concentrations 
(end product of lipid peroxidation) in 
streptozotocin-induced diabetic rats along with 
a significant decease in the antioxidant SOD 
activity are in conformation with previous 
reports documenting elevated serum lipid 
peroxide levels and diminished antioxidant 
status in diabetic subjects11. In this study, aloe 
supplementation results in suppressed free 
radical-induced oxidative damage. The 
superoxide dismutase (SOD) activity was 
increased in the aloe treated group and signs of 
oxidative tissue damage, such as lipid peroxide, 
were decreased. Can et al 12 found similar results 
in the treatment of neonatal streptozotocin-
induced type 2 diabetic rats. Can and coworkers 
reported that treatment with aloe decreased 
damage to liver, increased glutathione and 
decreased lipid peroxidation.  Reports of 
research indicating high blood sugar leads to 
increased oxidative stress and evidence of 
oxidative damage has been demonstrated in 
arterial samples from human diabetic subjects13.  
This damage is caused by reactive oxygen 
species that promote lipid peroxidation and play 
a serious role in the development of 
cardiovascular disease. In 2000, Singh and 
coworkers conducted an extensive study 
showing that oral dosing with aloe induced the 
phase II enzyme system (including SOD, 
catalase and glutathione peroxidase) of mice and 
significantly reduced lipid peroxidation14. 
 
And finally, in 2002 at the International Aloe 
Science Council (IASC) Annual Conference, 
Vinson Joe presented evidence from a human 
chemical study13, that the bioavailability of 
antioxidant supplement vitamins C and E was 
increased by over 200 percent when taken Aloe 
vera gel.  
 
The decreased activity of antioxidant molecular 
along with elevated lipid peroxide levels in 
diabetic rats could probably be associated with 
oxidative stress and/or decreased antioxidant 
defense potential15. The reversal in their content 
following treatment may be due to decreased 
oxidative load. The Aloe barbadensis leaf 
extracts may also act by either directly 
scavenging the reactive oxygen metabolites, due 
to the presence of various antioxidant 
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